Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.

Literature DB >> 22261338

RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.

Shadan Ali¹, Aamir Ahmad², Amro Aboukameel¹, Bin Bao², Subhash Padhye³, Philip A Philip¹, Fazlul H Sarkar⁴.

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor in Chief. An investigation by Wayne State University identified a discrepancy between the data reported in Figures 1 A and 3 and the original collected data. The investigation committee concluded that this undermined the scientific basis of the publication, that no credible replacement data were available, and advised that the publication should be retracted.

Entities: CellLine Chemical Disease Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22261338 PMCID： PMC3326199 DOI： 10.1016/j.canlet.2012.01.013

Source DB: PubMed Journal: Cancer Lett ISSN： 0304-3835 Impact factor: 8.679

43 in total

1. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

Authors: E L Jackson; N Willis; K Mercer; R T Bronson; D Crowley; R Montoya; T Jacks; D A Tuveson
Journal: Genes Dev Date: 2001-12-15 Impact factor: 11.361

2. LIN28B confers radio-resistance through the posttranscriptional control of KRAS.

Authors: Sun-Hye Jeong; Hong-Gyun Wu; Woong-Yang Park
Journal: Exp Mol Med Date: 2009-12-31 Impact factor: 8.718

3. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Authors: Shadan Ali; Aamir Ahmad; Sanjeev Banerjee; Subhash Padhye; Kristin Dominiak; Jacqueline M Schaffert; Zhiwei Wang; Philip A Philip; Fazlul H Sarkar
Journal: Cancer Res Date: 2010-04-13 Impact factor: 12.701

4. RAS is regulated by the let-7 microRNA family.

Authors: Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal: Cell Date: 2005-03-11 Impact factor: 41.582

5. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

Authors: Yong Sun Lee; Anindya Dutta
Journal: Genes Dev Date: 2007-04-16 Impact factor: 11.361

6. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.

Authors: Kim M Smits; Trupti Paranjape; Sunitha Nallur; Kim A D Wouters; Matty P Weijenberg; Leo J Schouten; Piet A van den Brandt; Fred T Bosman; Joanne B Weidhaas; Manon van Engeland
Journal: Clin Cancer Res Date: 2011-10-12 Impact factor: 12.531

7. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras.

Authors: Jee-Sun Oh; Jae-Jin Kim; Ju-Yeon Byun; In-Ah Kim
Journal: Int J Radiat Oncol Biol Phys Date: 2010-01-01 Impact factor: 7.038

8. Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice.

Authors: Subhash Padhye; Sanjeev Banerjee; Deepak Chavan; Shubhangini Pandye; K Venkateswara Swamy; Shadan Ali; Jing Li; Q Ping Dou; Fazlul H Sarkar
Journal: Pharm Res Date: 2009-08-28 Impact factor: 4.200

9. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras.

Authors: Wing Pui Tsang; Tim Tak Kwok
Journal: Carcinogenesis Date: 2009-04-16 Impact factor: 4.944

10. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Authors: Yiwei Li; Timothy G VandenBoom; Dejuan Kong; Zhiwei Wang; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal: Cancer Res Date: 2009-08-04 Impact factor: 12.701

29 in total

1. Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.

Authors: Suzan Schwertheim; Frederik Wein; Klaus Lennartz; Karl Worm; Kurt Werner Schmid; Sien-Yi Sheu-Grabellus
Journal: J Cancer Res Clin Oncol Date: 2017-03-06 Impact factor: 4.553

2. Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer.

Authors: Jiang Yang; Tai Wang; Lina Zhao; Vinagolu K Rajasekhar; Suhasini Joshi; Chrysafis Andreou; Suchetan Pal; Hsiao-Ting Hsu; Hanwen Zhang; Ivan J Cohen; Ruimin Huang; Ronald C Hendrickson; Matthew M Miele; Wenbo Pei; Matthew B Brendel; John H Healey; Gabriela Chiosis; Moritz F Kircher
Journal: Nat Biomed Eng Date: 2020-07-13 Impact factor: 25.671

RETRACTED: Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells.

1. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras.

2. LIN28B confers radio-resistance through the posttranscriptional control of KRAS.

3. Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

4. RAS is regulated by the let-7 microRNA family.

5. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.

6. A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer.

7. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras.

8. Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice.

9. The miR-18a* microRNA functions as a potential tumor suppressor by targeting on K-Ras.

10. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

1. Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells.

2. Gold/alpha-lactalbumin nanoprobes for the imaging and treatment of breast cancer.

Review 3. Targeting CSC-related miRNAs for cancer therapy by natural agents.

Review 4. The role of cancer stem cells and miRNAs in defining the complexities of brain metastasis.

5. Systems and Network Pharmacology Approaches to Cancer Stem Cells Research and Therapy.

6. Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer.

7. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.

8. Biological and therapeutic activities, and anticancer properties of curcumin.

Review 9. Perspectives on new synthetic curcumin analogs and their potential anticancer properties.

Review 10. Pancreatic cancer chemoprevention by phytochemicals.